THE Australian Synchrotron will be among the first users of Bluechiip’s tough MEMS-based wireless tracking technology.
Other than the Australian Synchrotron, Australia-based Bluechiip said it has also sold its technology to a number of other customers, including a genomics and clinical laboratory in North Carolina, USA, a hospital in Shanghai, and Victoria’s Southern Health.
The Bluechiip technology is aimed at the healthcare, life science, security, defence and manufacturing industries. It seeks to supplant labels, barcodes and RFID-based resources tracking technology with MEMS-based tags.
These tags are able to survive the tough processing used in the healthcare industry, do not require line of sight, and can also sense the temperature of the items that they are attached to, providing an additional dimension of data.
According to Iain Kirkwood, executive chairman of Bluechiip, these new sales indicate that the new strategic direction for the company is producing results. Bluechiip will continue to pursue further sales orders and seek to showcase its tracking platforms at international venues.
The company has also signed a co-development agreement with Micronic B.V, which will see its technology incorporated into a dual identity vial.